ALEXANDRIA, Va. - To underscore its commitment to scale and grow cancer research funding and to align more closely with the American Society of Clinical Oncology (ASCO), today Conquer Cancer®, the ASCO Foundation, updated its mission and vision.
Mission: Accelerate breakthroughs in lifesaving research and empower people everywhere to conquer cancer.
Vision: A world where cancer is prevented or cured, and every survivor is healthy.
ALEXANDRIA, Va. - Conquer Cancer, the ASCO Foundation, is pleased to announce David W. Lim, MDCM, MEd, PhD, of Women's College Hospital in Toronto, Ontario, Canada, as the recipient of the 2021 Conquer Cancer - Lobular Breast Cancer Alliance (LBCA) Young Investigator Award (YIA) for Invasive Lobular Carcinoma (ILC) Research.
ALEXANDRIA, Va. - Conquer Cancer, the ASCO Foundation, is pleased to announce Shlomit Strulov Shachar, MD, of Tel Aviv Sourasky Medical Center as the recipient of the 2021 Conquer Cancer - Israel Cancer Research Fund Career Development Award (CDA).
Alexandria, Va. - Conquer Cancer, the ASCO Foundation, is pleased to announce the recipients of its 2021 ASCO Registry Research Grants.
Conquer Cancer established the ASCO Registry Research Grant to support research using data derived from the ASCO Survey on COVID-19 in Oncology Registry (the “ASCO Registry”). The ASCO Registry informs the cancer community about the patterns of symptoms and severity of COVID-19 among patients with cancer, as well as how COVID-19 is impacting the delivery of cancer care and patient outcomes.
Lori Pierce, MD, FASTRO, FASCO, is the President of the American Society of Clinical Oncology (ASCO) for the 2020-2021 term. In a Q&A with Conquer Cancer, the ASCO Foundation, Dr. Pierce reflects on why ASCO and Conquer Cancer are calling on donors to help expand equity-centric programs and research opportunities. She draws on personal experiences and data around existing disparities to explain why advancing equity in cancer care helps every patient.
ALEXANDRIA, Virginia (June 4. 2021) – Conquer Cancer, the ASCO Foundation, today announced a collaboration with Pfizer Global Medical Grants to support research to promote and advance scientific knowledge concerning equitable care of patients with metastatic breast cancer (mBC).